PURE Bioscience (OTCMKTS:PURE) Shares Shorted: Short Interest Down 77.3% in October

PURE Bioscience (OTCMKTS:PURE) was the recipient of a large decrease in short interest during the month of October. As of October 15th, there was short interest totaling 4,381 shares, a decrease of 77.3% from the September 30th total of 19,268 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average trading volume of 65,650 shares, the short-interest ratio is currently 0.1 days.

PURE Bioscience Stock Performance

OTCMKTS:PURE traded up $0.00 during mid-day trading on Wednesday, hitting $0.07. 11,100 shares of the company’s stock traded hands, compared to its average volume of 31,727. The firm’s 50 day simple moving average is $0.07 and its 200 day simple moving average is $0.07. PURE Bioscience has a 1 year low of $0.04 and a 1 year high of $0.10.

PURE Bioscience Company Profile

PURE Bioscience, Inc develops and commercializes antimicrobial products based on its proprietary silver dihydrogen citrate (SDC) technology. SDC is designed to provide broad-spectrum antimicrobial activity and is used as an active ingredient in formulations intended for applications such as surface disinfection, sanitation and odor control.

The company’s product portfolio has included PureGreen24, a disinfectant and sanitizer marketed for use on hard, nonporous surfaces in commercial, institutional, industrial and residential settings.